Main /
Capabilitiesmain /
InsightsMain /
EventsSPEAKING ENGAGEMENT
Webinar
July 16, 2020
July 16, 2020
Brian M. Bunn joins Carta to analyze trends in healthcare and life sciences. The panel will also discuss company formation, balancing operations with science needs, and understanding the current fundraising climate.
Brian M. Bunn represents clients in the full range of corporate transactions and financings, including mergers, stock and asset purchases and sales, venture capital investments, joint ventures, restructurings and recapitalizations. Brian has deep experience in the life sciences, healthcare, medical device and technology fields. He also advises clients with interests and operations in the food and beverages, energy and manufacturing industries, among other sectors. Brian leads the Boston corporate practice.
Brian regularly counsels emerging companies, particularly in the life sciences and technology fields, from start-up through seed, debt and equity financings, commercial contracts, acquisitions and dispositions. He also acts as outside general counsel to a number of companies.
Brian’s international experience includes transactions involving businesses in Asia, Europe and Central America.
Do not send any information or documents that you want to have treated as secret or confidential. Providing information to McDermott Will & Schulte via email links on this website or other introductory email communications will not create an attorney-client relationship; will not preclude McDermott Will & Schulte from representing any other person or firm in any matter; and will not obligate McDermott Will & Schulte to keep confidential the information you provide. McDermott Will & Schulte cannot enter into an attorney-client relationship with you until McDermott Will & Schulte has determined that doing so will not create a conflict of interest and until you and McDermott Will & Schulte have entered into a written agreement or engagement letter that sets forth the terms of our relationship.
